EnteroMedics

homesitemapcontact us

   search

 

   
 
 
   
   
 

Top News

 
 

Archives 2017

 
 

Archives 2016

 
 

Archives 2015

 
 

Archives 2014

 
 

Archives 2013

 
 

Archives 2012

 
 

Archives 2011

 
 

Archives 2010

 
 

Archives 2009

 
 

Publications

 

Press Kit

 
 

Media Contact

 

For press inquiries, please contact:

Media Contact:
EnteroMedics
651-634-3003

 

 

 

 

 

2016 |2015 |2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006

2016

John M. Morton, Sajani N. Shah, Bruce M. Wolfe, Caroline M. Apovian, Christopher J. Miller, Katherine S. Tweden, Charles J. Billington, Scott A. Shikora
Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study
Obesity Surgery – Journal Article – 2016

Pavlos Papasavas, Maher El Chaar, Shanu N. Kothari, on behalf of the American Society for Metabolic and Bariatric Surgery Clinical Issues Committee
American Society for Metabolic and Bariatric Surgery position statement on vagal blocking therapy for obesity
Surgery for Obesity and Related Diseases – 2016

2015

Scott A. Shikora, James Toouli, Miguel F Herrera, Bård Kulseng, Roy Brancatisano, Lilian Kow, Juan P. Pantoja, Gjermund Johnsen, Anthony Brancatisano, Katherine S. Tweden, Mark B. Knudson, Charles J. Billington
Intermittent Vagal Nerve Block for Improvements in Obesity, Cardiovascular Risk Factors, and Glycemic Control in Patients with Type 2 Diabetes Mellitus: 2-Year Results of the VBLOC DM2 Study
Obesity Surgery – Journal Article - 2015

Scott A. Shikora, Bruce M. Wolfe, Caroline M. Apovian, Mehran Anvari, David B. Sarwer, Robert D. Gibbons, Sayeed Ikramuddin, Christopher J. Miller, Mark B. Knudson, Katherine S. Tweden, Michael G. Sarr, Charles J. Billington
Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial
Journal of Obesity – Journal Article – 2015

2014

Sayeed Ikramuddin, Robin P. Blackstone, Anthony Brancatisano, James Toouli, Sajani N. Shah, Bruce M. Wolfe, Ken Fujioka, James W. Maher, James Swain, Florencia G. Que, John M. Morton, Daniel B. Leslie, Roy Brancatsiano, Lilian Kow, Robert O’Rourke, Clifford Deveney, Mark Takata, Christopher J. Miller, Mark B. Knudson, Katherine S. Tweden, Scott S. Shikora, Michael G. Sarr, Charles J. Billington
Effect of Reversible Intermittent Intra-abdominal Vagal Nerve Blockade on Morbid Obesity The ReCharge Randomized Clinical Trial
Journal of the American Medical Association - Journal Article - 2014

2013

Scott Shikora, James Toouli, Miguel Herrera, Baard Kulseng, Henryk Zulewski, Roy Brancatisano, Lilian Kow, Juan Pablo Pantoja, Gjermund Johnsen, Anthony Brancatisano, Katherine S. Tweden, Mark Knudson, Charles Billington
Vagal Blocking Improves Glycemic Control and Elevated Blood Pressure in Obese Subjects with Type 2 Diabetes Mellitus
Journal of Obesity - Journal Article - 2013

2012

Katherine S. Tweden, Mark Knudson, Scott Shikora, Robert Cary
Intermittent Neural Transmission Block Of The Intra-abdominal Vagus Induces Sustained Blood Pressure Reduction In Obese Subjects
American Heart Association (AHA) 2012 - Poster

Michael Sarr, Charles J Billington, Roy Brancatisano, Anthony Brancatisano, James Toouli, Lilian Kow, Ninh T Nguyen, Robin Blackstone, James W Maher, Scott Shikora, Dominic N Reeds, J. Christopher Eagon, Bruce M Wolfe, Robert W O’Rourke, Ken Fujioka, Mark Takata, James M Swain, John M Morton, Sayeed Ikramuddin, Michael Schweitzer, Bipan Chand, Raul Rosenthal
The EMPOWER Study: Randomized, Prospective, Double-Blind, Multicenter Trial of Vagal Blockade to Induce Weight Loss in Morbid Obesity
Obesity Surgery - Journal Article - 2012

James Toouli, Miguel Herrera, Baard Kulseng, Roy Brancatisano, Juan Pablo Pantoja, Gjermund Johnsen, Anthony Brancatisano, Katherine Tweden, Lilian Kow
Vagal Blocking: Treatment of Obesity Related Type 2 Diabetes and Blood Pressure—18 Month Results
Obesity Surgery Society of Australia & New Zealand (OSSANZ) 2012 - Oral
International Federation for the Surgery of Obesity (IFSO-EU) 2012 - Oral

2011

Miguel Herrera, James Toouli, Baard Kulseng, Roy Brancatisano, Henryk Zulewski, Juan Pablo Pantoja, Lilian Kow, Gjermund Johnsen, Anthony Brancatisano, Daniel M. Frey, James Freston, Katherine S. Tweden, Charles J. Billington
Treatment of Obesity-Related Type 2 Diabetes With Vagal Blocking
The Obesity Society 2011 - Poster

Nicholas Wray, Lilian Kow, Jane Collins, Katherine S. Tweden, James Toouli
Reduced Calorie Intake and Weight Loss During Vagal Blocking in Subjects with Obesity-Related Type 2 Diabetes Mellitus
Obesity 2011;19:S190 (presented at annual meeting The Obesity Society, Orlando, Florida, October 2011).

Jon Waataja, Katherine S Tweden, Christopher Honda
Effects of high-frequency alternating current on axonal conduction through the vagus nerve
Journal of Neural Engineering - Journal Article 2011

Herrera M, Toouli J, Kulseng B, Brancatisano R, Zulewski H, Pantoja JP, Kow L, Johnsen G, Brancatisano A, Frey D, Tweden K, Billington C
Treatment of obesity related co-morbidities with vBloc® Therapy
Obesity Surgery 2011;21:998 (IFSO Conference 2011, 31st August to 3rd September 2011, Hamburg, Germany).

Lilian Kow, Miguel Herrera, Baard Kulseng, Roy Brancatisano, Henryk Zulewski, Anthony Brancatisano, Juan Pablo Pantoja, Gjermund Johnsen, Daniel Frey, Katherine Tweden, James Toouli
Vagal Blocking For The Treatment Of Obesity Delivered Using The Fully Implantable Maestro Rechargeable System: 12 Month Results
American Society for Metabolic and Bariatric Surgery (ASMBS) 2011—Oral

Waataja J, Tweden K, Honda C: Effects of high-frequency alternating current on axonal conduction through the vagus nerve. Journal of Neural Engineering 2011;8:1741-1747.
Kow L, Herrera M, Kulseng B, Brancatisano R, Zulewski H, Brancatisano A, Pantoja JP, Johnsen G, Frey D, Tweden K, Toouli J
Vagal Blocking For The Treatment Of Obesity Delivered Using The Fully Implantable Maestro Rechargeable System: 12 Month Results.
Surgery for Obesity and Related Diseases 2011;3:363-364 (presented at Annual Meeting ASMBS, Orlando, FL June 2011).

Toouli J, Wray N, Collins J, Coles A, Tweden KS, Kow L.
Reduced Calorie Intake And Weight Loss During Vagal Block (vBloc® Therapy) In Morbidly Obese Patients With Type 2 Diabetes Mellitus
Gastroenterology 2011;140:S619 (presented at annual meeting, Digestive Disease Week, Chicago, IL, 7-10 May, 2011.
 

2010

Collins J, Wray N, Kow L, Coles A, Tweden KS, Toouli J.
Reduced Calorie Intake and Weight Loss During Vagal Block (vBloc® Therapy) In Morbidly Obese Patients with Type 2 Diabetes Mellitus
(presented at Annual Meeting, Obesity Surgery Society of Australia and New Zealand, OSSANZ) Conference 2010;10-12 November, 2010, Hobart, Tasmania; Conference Program Handbook, page 20.

Kow, L, Herrera M, Kulseng B, Brancatisano R, Zulewski H, Brancatisano A, Pantoja, JP, Johnsen G, Frey DM, Tweden KS, Toouli J.
Vagal Blocking Improves Obesity-Related Co-Morbidities in Obese Subjects with Type 2 Diabetes Mellitus
(presented at Annual Meeting, Obesity Surgery Society of Australia and New Zealand, OSSANZ) Conference 2010;10-12 November, 2010, Hobart, Tasmania; Conference Program Handbook, page 16.

Brancatisano R, Brancatisano A, Kow, L, Toouli J.
EMPOWER: A 12-Month Randomized, Prospective Clinical Trial: Safety And Effectiveness of vBloc® Therapy: Australian Experience
(presented at Annual Meeting, Obesity Surgery Society of Australia and New Zealand, OSSANZ) Conference 2010;10-12 November, 2010, Hobart, Tasmania; Conference Program Handbook, page 14.

Brancatisano R, Toouli J, Nguyen N, Blackstone R, Maher J, Shikora S, Reeds D, Wolfe B, Fujioka K, Swain J, Morton J, Ikramuddin S, Schweitzer M, Chand B, Rosenthal R, Brancatisano A, Kow L, Eagon C, Takata M, O’Rourke R, Sarr M, Billington C.
EMPOWER: A 12-Month Randomized, Prospective Clinical Trial: Safety And Effectiveness of vBloc® Therapy
(presented at Annual Meeting, Obesity Surgery Society of Australia and New Zealand, OSSANZ) Conference 2010;10-12 November, 2010, Hobart, Tasmania; Conference Program Handbook, page 14.

Herrera MF, Pantoja, JP, Brancatisano R, Brancatisano A, Zulewski H, Frey, DM, Kulseng B, Johnsen G, Toouli J, Kow L, Tweden KS, Vollmer, MC, Wilson, RR, Billington, CJ.
Vagal Blocking Improves Glycemic Control and Blood Pressure in Subjects with Type 2 Diabetes and Hypertension
Surgery for Obesity and Related Diseases 2010:6:PL-316 (presented at Annual Meeting, American Society for Metabolic and Bariatric Surgery, Las Vegas, NV, 21-26 June, 2010).

2009

Herrera MF, Kow L, Pantoja JP, Knudson M, Tweden KS, Wilson RR, Yurik T, Toouli J.
vBloc® and Improvements in Co-Morbidities in Obese Subjects During Weight Loss
Obesity Surgery 2009;19:983-984 (presented at Annual Meeting, International Federation for the Surgery of Obesity, Paris, France, 26-29 August, 2009).

Herrera MF, Burton D, Pantoja JP, Leenheer S, Bachmann B, Valdovinos M, Knudson M, Tweden KS, Wilson RR, Camilleri M.
Intermittent Vagal Blocking with an Implantable Device Reduces Maximum Tolerated Volume (MTV) During a Standardized Nutrient Drink Test in Obese Subjects
Obesity Surgery 2009;19:1012 (presented at Annual Meeting, International Federation for the Surgery of Obesity, Paris, France, 26-29 August, 2009).

Herrera MF, Brancatisano R, Keller U, Kulseng B, Toouli J, Brancatisano A, Frey DM, Kow L, Johnsen G, Pantoja JP, Bhole D, Carey RM, Tweden KS, Wilson RR, Billington CJ.
Intermittent Vagal Blockade with an Implantable Device Improves Glycemic Control in Obese Subjects with Type 2 Diabetes Mellitus
Surgery for Obesity and Related Diseases 2009;5:S48-S49 (presented at Annual Meeting, American Society for Metabolic and Bariatric Surgery, Dallas, TX, 21-26, June 2009).

Billington CJ, Kow L, Collins J, Wray N, Tweden KS, Vollmer MC, Wilson RR, Yurik TM, Freston JW, Toouli J.
Correlations Between Enhanced Satiety and Reduced Calorie Intake During Intermittent Vagal Block (vBloc® Therapy) to Treat Obesity
Gastroenterology 2009;136:A386 (presented at Annual Meeting, Digestive Disease Week, Chicago, IL, 30 May – 4 June 2009).

Herrera MF, Burton D, Pantoja JP, Sanchez-Leenheer S, Bachmann B, Valdovinos M, Bhole D, Prindle S, Tweden KS, Vollmer MC, Wilson RR, Camilleri M.
Intermittent Vagal Blocking with an Implantable Device Reduces Maximum Tolerated Volume (MTV) During a Standardized Nutrient Drink Test in Obese Subjects
Gastroenterology 2009;136:A386 (presented at Annual Meeting, Digestive Disease Week, Chicago, IL, 30 May – 4 June 2009).

Brancatisano R, Brancatisano A, Kow L, Bierk MD, Prindle S, Tweden KS, Wilson RR, Toouli J.
Implant Technique of a Novel Vagal Blockade Medical Device for the Treatment of Obesity
(presented at Annual Meeting, Obesity Surgery Society of Australia and New Zealand (IFSO-APC OSSANZ), Conference 2009; 25-27th March 2009 Hilton Cairns, Queensland; Conference Program Handbook, page 14.

Wray N, Billington CJ, Kow L, Collins J, Tweden KS, Vollmer MC, Wilson RR, Yurik TM, Freston JW, Toouli J.
Correlation between Enhanced Satiety and Reduced Calorie Intake during Intermittent Vagal Block (vBloc® Therapy) to Treat Obesity
(presented at Annual Meeting, Obesity Surgery Society of Australia and New Zealand, (IFSO-APC OSSANZ), Conference 2009; 25-27th March 2009 Hilton Cairns, Queensland; Conference Program Handbook, page 14.

Brancatisano A, Brancatisano R, Tweden KS, Vollmer MC, Wilson RR, Yurik TM, Kow L, Toouli J.
Intermittent Vagal Block with an Implantable Medical Device Improves Blood Pressure in Obese Subjects
(presented at Annual Meeting, Obesity Surgery Society of Australia and New Zealand, (IFSO-APC OSSANZ), Conference 2009; 25-27th March 2009 Hilton Cairns, Queensland; Conference Program Handbook, page 14.

Kow L, Brancatisano A, Brancatisano R, Collins J, Hutchison R, Tweden KS, Vollmer MC, Wilson RR, Toouli J.
Selecting Vagal Blocking Electrical Algorithms for Obesity Treatment
(presented at Annual Meeting, Obesity Surgery Society of Australia and New Zealand, (IFSO-APC OSSANZ), Conference 2009; 25-27th March 2009 Hilton Cairns, Queensland; Conference Program Handbook, page 14.

Camilleri M, Toouli J, Herrera MF, Kow L, Pantoja JP, Billington CJ, Tweden KS, Wilson RR, Moody FG.
Selection of Electrical Algorithms to Treat Obesity with Intermittent Vagal Block Using An Implantable Medical Device
Surgery for Obesity and Related Diseases 2009;5:224-230.

2008

Wilson RR, Toouli J, Kow L, Keller U, Frey DM, Kulseng B, Johnsen G, Marvik R, Tweden KS, Freston JW, Pritchett ELC, Billington CJ.
Intra-abdominal Vagal Blocking Reduces Body Weight with Associated Reductions in Heart Rate and without Adverse Effect on Electrocardiographic Parameters
Obesity Surgery 2008;18:923 (presented at Annual Meeting, International Federation for the Surgery of Obesity, Buenos Aires, Argentina, 24-27 September 2008).

Kow L, Toouli J, Freston JW, Tweden KS, Wilson RR, Moody FG.
Comparison of Food Ingestion Disorders with Three Devices for Obesity Treatment
Obesity Surgery 2008;18:914 (presented at Annual Meeting, International Federation for the Surgery of Obesity, Buenos Aires, Argentina, 24-27 September 2008).

Herrera MF, Pantoja JP, Frey DM, Tweden KS, Bierk MD.
Implantation Technique of a Rechargeable Vagal Blocking System for Treatment of Obesity
Obesity Surgery 2008;18:946 (presented at Annual Meeting, International Federation for the Surgery of Obesity, Buenos Aires, Argentina, 24-27 September 2008).

Kow L, Herrera MF, Pantoja JP, Tweden KS, Wilson RR, Billington CJ, Toouli J.
Selecting Vagal Blocking Electrical Algorithms for Obesity Treatment
Obesity Surgery 2008;18:924 (presented at Annual Meeting, International Federation for the Surgery of Obesity, Buenos Aires, Argentina, 24-27 September 2008).

Toouli J, Kulseng B, Keller U, Kow L, Marvik R, Johnsen G, Frey D, Tweden KS, Wilson RR, Billington CJ, Moody FG.
Vagal Blocking for Obesity Control: Ongoing Comparison of Weight Loss with Two Generations of an Active, Implantable Medical Device
Surgery for Obesity and Related Diseases 2008;4:305 (presented at Annual Meeting, American Society for Metabolic and Bariatric Surgery, Washington, DC, 15-20 June 2008).

Camilleri M, Toouli J, Herrera MF, Kulseng B, Kow L, Pantoja JP. Marvik R, Johnsen G, Billington CJ, Moody FG, Knudson MB, Tweden KS, Vollmer MC, Wilson RR, Anvari M.
Intra-abdominal Vagal Blocking (vBloc® Therapy): Clinical Results with a New Implantable Medical Device
Surgery: Journal of the Society of University Surgeons 2008;143:723-731.

Toouli J, Kow L, Collins J, Wray NH, Tweden KS, Vollmer MC, Wilson RR, Freston JW, Billington CJ.
Intra-abdominal Vagal Blocking Reduces Calorie Intake, Enhances Satiation and Reduces Hunger during Significant and Sustained Weight Loss in Obese Subjects
Gastroenterology 2008;134(Suppl 1):A370. (presented at Annual Meeting, American Gastroenterology Association/Digestive Diseases Week, San Diego, CA, 17-22 May 2008).

Kow L, Billington CJ, Kendrick ML, Sarr MG, Bierk MD, Tweden KS, Wilson, RR, Toouli J.
An Implantable Vagal Blocking System to Treat Obesity: Laparoscopic Implantation Technique and Early Results in a Proof-of-principle Clinical Study
(presented at Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Annual Meeting, Philadelphia, PA, USA 9-12 April 2008; ET 17, page 295).

Toouli J, Kulseng B, Keller U, Kow L, Marvik R, Johnsen G, Frey MD, Tweden KS, Wilson RR, Billington CJ.
Vagal Blocking for Obesity Control (VBLOC): Interim Six-month Results in an Ongoing Trial Using a Second Generation System
Surgical Endoscopy 2008;22:S194 (presented at Annual Meeting, Society of American Gastrointestinal and Endoscopic Surgeons, Philadelphia, PA, April 2008).

2007

Camilleri M, Herrera MF, Kow L, Pantoja JP, Toouli J, Billington CJ, Freston JW, Knudson MB, Vollmer MC, Wilson RR, Tweden KS.
Vagal Blocking for Obesity Control (VBLOC): Plasma Pancreatic Polypeptide (PPP) Response to a Standardized Sham Meal Challenge
Obesity 2007;15:A6-A7 (presented at Annual Meeting, The Obesity Society/North American Association for the Study of Obesity, October 2007).

Toouli J, Collins J, Wray N, Billington CJ, Knudson MB, Pulling CC, Tweden KS, Vollmer MC, Wilson RR, Kow L.
Vagal Blocking for Obesity Control (VBLOC): Effects on Excess Weight Loss, Calorie Intake, Satiation and Satiety
Obesity Surgery 2007;17:1043 (presented at Annual Meeting, International Federation for the Surgery of Obesity, Porto, Portugal, September 2007).

Kow L, Herrera MF, Kulseng B, Marvik R, Pantoja JP, Anvari M, Bierk MD, Freston JW, Knudson MB, Tweden KS, Vollmer MC, Wilson RR, Toouli J.
Vagal Blocking for Obesity Control (VBLOC): An Open-label Study of an Implantable, Programmable Medical Device to Treat Obesity
Obesity Surgery 2007;17:1043 (presented at Annual Meeting, International Federation for the Surgery of Obesity, Porto, Portugal, September 2007).

2006

Tweden KS, Toouli J, Kow L, Herrera M, Pantoja JP, Bierk MD, Knudson MB, Wilson RR, Anvari M.
Vagal Blocking for Obesity Control (VBLOC): Studies of Pancreatic Function and Safety in a Porcine Model
Obesity Surgery 2006;16:988. (presented at Annual Meeting, International Federation for the Surgery of Obesity, Sydney, Australia, August 2006).

Tweden KS, Sarr MG, Bierk MD, Camilleri M, Kendrick ML, Knudson MB, Moody FG, Wilson RR, Anvari M.
Vagal Blocking for Obesity Control (VBLOC): Studies of Pancreatic and Gastric Function and Safety in a Porcine Model
Surgery for Obesity and Related Diseases 2006;2:301 (presented at Annual Meeting, American Society for Bariatric Surgery, San Francisco, CA, June 2006).

Tweden KS, Anvari M, Bierk MD, Billington CJ, Camilleri M, Honda CN, Knudson MB, Larson DE, Wilson RR, Freston JW.
Vagal Blocking for Obesity Control (VBLOC): Concordance of Effects of Very High Frequency Vagal Blocking Currents at the Neural and Organ Levels Using Two Pre-clinical Models
Gastroenterology 2006;130 (Suppl 2):A-148 (presented at Annual Meeting, American Gastroenterology Association/Digestive Diseases Week, Los Angeles, CA, May 2006).